59 karma · joined September 6, 2024
In defense of a lot of these bioinformatics-specific rewrites, there are some really dodgy coding practices and bugs that exist in well used tools, so there is scope for genuine improvement. The most recent release of minimap2 fixed some bugs identified in a rewrite, for example: https://github.com/lh3/minimap2/releases/tag/v2.31
At the moment, it feels like releases like this overcommit and overpromise on "PhD level reasoning", which I wouldn't say is the absolute bottleneck in clinical research.
Fact is that a university that must simultaneously handle education, research, publishing, estate management, legal stuff, media coverage, health and safety etc etc etc ends up being somewhat bureaucratic.
I’d pitch this paper as a very solid demonstration of the approach, and im sure it will lead to some pretty rapid developments (similar to what Rosettafold/alphafold did)
The recently added support for PDF/A is also quite exciting, as I've never found a satisfactory solution to this with latex. Now I just wish journals would support markdown submissions...
Even now LinkedIn is possibly the worst platform for being polluted with "AI slop", I cannot understand why they are looking to advance this further. Hell, when you go to write a post now there is a big flashing button saying "USE AI TO WRITE THIS POST"...?!?!
LEEZWOO 15.6" Laptop - 16GB RAM 512GB SSD PC Laptop, Quad-Core N95 Processor Up to 3.1GHz, Laptop Computers with Touch ID, WiFi, BT4.2, for Students/Business
Name rolls off the tongue doesn’t it
The real benefit of python in bioinformatics is the number of libraries available that let you interact with a bunch of software, perhaps do some light analysis, maybe make some pretty plots. And if you want to do some more intensive "useful" analysis, then all the ML packages, numpy, polars etc are quite hard to dismiss.